Gene · 50604
Papers1,802
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,802
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Calpeptin and protein kinase C inhibition suppress exosome-associated inflammatory signaling and epidermal dysregulation in a 3-dimensional psoriatic skin model. | J Pharmacol Exp Ther | 2026 | 42731396 | PubTator, text mining | PubMed |
| The neuroimmune network in Alzheimer's and Parkinson's diseases: from mechanistic insights to biomarker-guided immunotherapies and clinical translation. | Inflammopharmacology | 2026 | 42627617 | PubTator, text mining | PubMed |
| Signal peptide-mediated endoplasmic reticulum targeting enhances antigen expression and secretion to improve mRNA vaccine efficacy. | Acta Biochim Biophys Sin (Shanghai) | 2026 | 42550669 | PubTator, text mining | PubMed |
| Proteomic landscapes of post-COVID condition: biomarkers and translational pathways. | Front Immunol | 2026 | 42421959 | PubTator, text mining | PubMed |
| Microwave treatment of human papillomavirus-positive in vitro grown epithelial tissues results in a rapid stress-related transcriptional response and induction of innate immunity. | Int J Hyperthermia | 2026 | 42381515 | PubTator, text mining | PubMed |
| Dynamics of the Interleukin-10 Family of Cytokines in Chronic Otitis Media Patients upon 1,8-Cineol Treatment. | In Vivo | 2026 | 42379782 | PubTator, text mining | PubMed |
| Early-life proteomic and microbiome features signal obesity risk across 26 years of follow-up. | mSystems | 2026 | 42206849 | PubTator, text mining | PubMed |
| Causal Interplay Between Inflammatory Cytokines and Lipid Metabolites in Serous Ovarian Carcinoma: Insights From a Genetic Association Study. | J Clin Lab Anal | 2026 | 42104642 | PubTator, text mining | PubMed |
| DNA aptamers that inhibit binding to human interleukin-17A and interleukin-20. | RSC Adv | 2026 | 42017161 | PubTator, text mining | PubMed |
| Proliferation-associated protein 2G4 promotes keratinocyte proliferation and survival in psoriasis. | Br J Dermatol | 2026 | 42008715 | PubTator, text mining | PubMed |
| Divergent inflammatory and neurology-related protein levels in long COVID following primary and breakthrough SARS-CoV-2 infections. | Commun Med (Lond) | 2026 | 41975235 | PubTator, text mining | PubMed |
| Epigenetic and biomolecular mechanisms in chronic temporomandibular disorder-related pain: an integrative review. | Mol Biol Rep | 2026 | 41925889 | PubTator, text mining | PubMed |
| Interleukin-24 in type 2 immune diseases. | Front Immunol | 2026 | 41909717 | PubTator, text mining | PubMed |
| CXCL12 and eotaxin are independent prognostic serum biomarkers in gastric cancer. | Sci Rep | 2026 | 41906027 | PubTator, text mining | PubMed |
| Single-cell analysis of TIGD genes in hepatocellular carcinoma: Prognostic value and functional characterization. | Transl Oncol | 2026 | 41775084 | PubTator, text mining | PubMed |
| From concept to practice: real-world safety of JAK inhibitors in rheumatoid arthritis treatment. | Front Med (Lausanne) | 2026 | 41767496 | PubTator, text mining | PubMed |
| Dermal Fibroblasts, Not Keratinocytes, Dominate IL-17A/TNF-Driven Inflammation. | Exp Dermatol | 2026 | 41755670 | PubTator, text mining | PubMed |
| Oncostatin M upregulates CD73 via the MAPK pathway in keratinocytes to promote an adenosine-dependent anti-inflammatory response in psoriasis. | Front Immunol | 2026 | 41727450 | PubTator, text mining | PubMed |
| Molecular classification and prognosis study of pancreatic ductal adenocarcinoma through multi-omics integrated clustering analysis. | PeerJ | 2026 | 41727227 | PubTator, text mining | PubMed |
| The role and mechanism of IL‑35 in myasthenia gravis (Review). | Int J Mol Med | 2026 | 41716022 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/50604/papers